Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00217269 · ClinicalTrials.gov registry record · NA
The ENDEAVOR IV Clinical Trial: A Trial of a Coronary Stent System in Coronary Artery Lesions
A NA study, sponsored by Medtronic Vascular.
- Completed
- Registry status
- NA
- Development phase
- 1,548
- Enrollment target
NCT00217269: Completed NA study, sponsored by Medtronic Vascular.
NCT00217269 is a NA study that has completed, run by Medtronic Vascular. The registered enrollment target is 1,548 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (10% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00217269, a NA study, has completed, sponsored by Medtronic Vascular.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,548 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the equivalence in safety and efficacy of the Endeavor Drug Eluting Coronary Stent System when compared to the Taxus Paclitaxel-Eluting Coronary Stent System for the treatment of single de novo lesions in native coronary arteries with a reference vessel diameter (RVD) of 2.5-3.5 mm.
Interventions
- DEVICE Coronary Artery Stenting
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,548 participants |
| Start Date | 2005-04 |
| Est. Completion | 2011-07 |
| Phase | NA |
What the finished NCT00217269 record still lists
NCT00217269 is an interventional study that assigns participants to a tested intervention. Its 1,548 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (10% higher).
The record links to 0 conditions, and to 1 intervention - of which Coronary Artery Stenting is the first listed.
NCT00217269 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00217269 about?
NCT00217269 is a clinical study titled "The ENDEAVOR IV Clinical Trial: A Trial of a Coronary Stent System in Coronary Artery Lesions". The purpose of this study is to assess the equivalence in safety and efficacy of the Endeavor Drug Eluting Coronary Stent System when compared to the Taxus Paclitaxel-Eluting Coronary Stent System for the treatment of single de novo lesions in native coronary arteries with a reference vessel diamete...
What is the current status of trial NCT00217269?
This trial is currently completed. It is a NA study. The enrollment target is 1,548 participants. The study started on 2005-04. Estimated completion is 2011-07.
What interventions are being tested in trial NCT00217269?
The interventions under investigation include: Coronary Artery Stenting (DEVICE).
Who is sponsoring clinical trial NCT00217269?
This trial is sponsored by Medtronic Vascular, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00217269's enrollment target sits among peer trials
1,548 65th of 2000 higher than 1,936 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02650622 · 1,550 participants
Genetic and Metabolic Disease in Children
- NCT03961945 · 1,550 participants · NA
Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma
- NCT06729775 · 1,546 participants · NA
Disentangling the Role of Culture, Life Stage, and Information Design to Facilitate Equity in Data Report Back
- NCT03435796 · 1,541 participants · Phase 2
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia